I'm pretty much in the middle of the fence with this one. I'm holding a significant share count. If they pull off getting a drug to market by means of acquisition or partnership, heck yeah SBFM. So far this company is only put out red herring from a speculative standpoint. They weren't even honest enough to let the investors know they failed QB uplifting. So yeah, until this company does what it hasn't done at all in the entirety of the company, it's a goddamn snake oil salesman.